Drug properties relevant to sustained
            release formulation
The design of sustained release delivery system is
  subjected to several variables and each of variables
  are inter-related
For the purpose of discussion it is convenient to
  describe the properties of the drugs as being either
  physico-chemical or biological ,these may be divided
  in two types.
1. Physicochemical properties
2. Biological properties
1.Physicochemical properties


A. Aqueous solubility and pKa
B. Partition coefficient
C. Drug stability
D. Protein binding
A. Aqueous solubility and pKa
These are the most important to influence its absorptive
  behavior and its aqueous solubility ( if it’s a weak acid or
  base) and its pKa
The aqueous solubility of the drug influences its dissolution
  rate which in turn establishes its concentration in
  solution and hence the driving force for diffusion across
  the membranes as shown by Noye’s Whitney’s equation
  which under sink condition that is
         dc/dt= Kd.A.Cs
Where dc/dt = dissolution rate
  Kd= dissolution rate constant
  A = total surface area of the drug particles
  Cs= aqueous solubility of the drug
Dissolution rate (dc/dt) is constant only when Surface
Area A .is
The initial rate is directly proportional to the Aqueous
solubility (Cs) hence Drug with low aqueous solubility
have low dissolution rate and its suffer low bioavailability
problem
The aqueous solubility of weak acid and bases are
controlled by pKa of the compound and pH the medium
For weak acids
St= So(1+Ka/H+) = So (1+10pH-pKa )
Where St = total solubility of weak acid.
So = solubility of unionized form
Ka= Acid dissociation constant
H+= H ion concentration
Similarly for Weak Bases
St = So (1+H+/Ka) = So (1+10pKa-pH )
if a poorly soluble drug was consider as a suitable candidate
for formulation into sustained release system.
Since weakly acidic drugs will exist in the stomach pH 1-2 ,
primarily in the unionized form their absorption will be
favored from this acidic environment on the other hands
weakly basic drugs will be exist primarily in the ionized form
(Conjugate Acids) at the same site, their absorption will be
poor.
in the upper portion of the small intestine the pH is more
alkaline
pH 5-7 and the reverse will be expected for weak acids
B. Partition coefficient
When the drug is administered to the GIT ,it must cross a
variety of biological membranes to produce therapeutic
effects in another area of the body.
It is common to consider that these membranes are lipidic,
therefore the Partition coefficient of oil soluble drugs
becomes important in determining the effectiveness of
membranes barrier penetration.
Partition coefficient is defined as the ratio of the fraction of
the drug in an oil phase to that of an aqueous phase.
Accordingly compounds with a relatively higher partition
coefficient are predominantly lipid soluble and have very low
aqueous solubility.
Furthermore , these compound can usually persist in the
body for long periods , because they can localize in the lipid
membranes


Phenothiazines are representative of this type of compound


Compounds with very low partition coefficients will have
difficulty penetrating membranes , resulting in poor bio
availability
C. Drug stability


Orally administered drugs can be subjected to both acid-
base hydrolysis and enzymatic degradation .


 Degradation will proceed at a reduced rate for drugs in the
solid state therefore this is preferred composition of delivery
for problem cases .
Drugs that are unstable in the stomach can be placed in
slowly soluble form or have their release delayed until they
reach small intestine.
However for some drugs which are unstable in small
intestine are under go extensive Gut –Wall metabolism have
decreased the bio availability .
When these drugs are administered from a sustained
dosage form to achieve better bio availability, at different
routes of the drugs administered should be chosen
Eg. Nitroglycerine


The presence of metabolizing enzymes at the site or pathway
can be utilized.
D. Protein binding
The binding of the drugs to plasma proteins(eg.Albumin)
 results in retention of the drug into the vascular space
the drug protein complex can serves as reservoir in the
vascular space for sustained drug release to extra
vascular tissue but only for those drugs that exhibited a
high degree of binding.
The main force of attraction are Wander-vals forces ,
hydrogen binding, electrostatic binding.
In general charged compound have a greater tendency to
bind a protein then uncharged compound, due to
electrostatic effect.
The presence of hydrophobic groups on drug
molecule also increases its binding potential.
Eg amitryptline, cumarin, diazepam, digoxide,
dicaumarol, novobiocin.

Sustained release property

  • 1.
    Drug properties relevantto sustained release formulation The design of sustained release delivery system is subjected to several variables and each of variables are inter-related For the purpose of discussion it is convenient to describe the properties of the drugs as being either physico-chemical or biological ,these may be divided in two types. 1. Physicochemical properties 2. Biological properties
  • 2.
    1.Physicochemical properties A. Aqueoussolubility and pKa B. Partition coefficient C. Drug stability D. Protein binding
  • 3.
    A. Aqueous solubilityand pKa These are the most important to influence its absorptive behavior and its aqueous solubility ( if it’s a weak acid or base) and its pKa The aqueous solubility of the drug influences its dissolution rate which in turn establishes its concentration in solution and hence the driving force for diffusion across the membranes as shown by Noye’s Whitney’s equation which under sink condition that is dc/dt= Kd.A.Cs Where dc/dt = dissolution rate Kd= dissolution rate constant A = total surface area of the drug particles Cs= aqueous solubility of the drug
  • 4.
    Dissolution rate (dc/dt)is constant only when Surface Area A .is The initial rate is directly proportional to the Aqueous solubility (Cs) hence Drug with low aqueous solubility have low dissolution rate and its suffer low bioavailability problem The aqueous solubility of weak acid and bases are controlled by pKa of the compound and pH the medium For weak acids St= So(1+Ka/H+) = So (1+10pH-pKa ) Where St = total solubility of weak acid. So = solubility of unionized form Ka= Acid dissociation constant H+= H ion concentration
  • 5.
    Similarly for WeakBases St = So (1+H+/Ka) = So (1+10pKa-pH ) if a poorly soluble drug was consider as a suitable candidate for formulation into sustained release system. Since weakly acidic drugs will exist in the stomach pH 1-2 , primarily in the unionized form their absorption will be favored from this acidic environment on the other hands weakly basic drugs will be exist primarily in the ionized form (Conjugate Acids) at the same site, their absorption will be poor. in the upper portion of the small intestine the pH is more alkaline pH 5-7 and the reverse will be expected for weak acids
  • 6.
    B. Partition coefficient Whenthe drug is administered to the GIT ,it must cross a variety of biological membranes to produce therapeutic effects in another area of the body. It is common to consider that these membranes are lipidic, therefore the Partition coefficient of oil soluble drugs becomes important in determining the effectiveness of membranes barrier penetration. Partition coefficient is defined as the ratio of the fraction of the drug in an oil phase to that of an aqueous phase. Accordingly compounds with a relatively higher partition coefficient are predominantly lipid soluble and have very low aqueous solubility.
  • 7.
    Furthermore , thesecompound can usually persist in the body for long periods , because they can localize in the lipid membranes Phenothiazines are representative of this type of compound Compounds with very low partition coefficients will have difficulty penetrating membranes , resulting in poor bio availability
  • 8.
    C. Drug stability Orallyadministered drugs can be subjected to both acid- base hydrolysis and enzymatic degradation .  Degradation will proceed at a reduced rate for drugs in the solid state therefore this is preferred composition of delivery for problem cases . Drugs that are unstable in the stomach can be placed in slowly soluble form or have their release delayed until they reach small intestine. However for some drugs which are unstable in small intestine are under go extensive Gut –Wall metabolism have decreased the bio availability .
  • 9.
    When these drugsare administered from a sustained dosage form to achieve better bio availability, at different routes of the drugs administered should be chosen Eg. Nitroglycerine The presence of metabolizing enzymes at the site or pathway can be utilized.
  • 10.
    D. Protein binding Thebinding of the drugs to plasma proteins(eg.Albumin) results in retention of the drug into the vascular space the drug protein complex can serves as reservoir in the vascular space for sustained drug release to extra vascular tissue but only for those drugs that exhibited a high degree of binding. The main force of attraction are Wander-vals forces , hydrogen binding, electrostatic binding. In general charged compound have a greater tendency to bind a protein then uncharged compound, due to electrostatic effect.
  • 11.
    The presence ofhydrophobic groups on drug molecule also increases its binding potential. Eg amitryptline, cumarin, diazepam, digoxide, dicaumarol, novobiocin.